Genosity to Investigate Genetics of Cardiac Amyloidosis
Jan 7, 2020
NEW YORK–(BUSINESS WIRE)–Genosity Inc. announced today that it has partnered with Columbia University Irving Medical Center to investigate genetic factors associated with wild-type cardiac amyloidosis, a type of heart failure caused by the buildup of amyloid protein.
Next Generation Dx Summit
Aug 20-22 2019, Washington, DC
Interested in learning about new data strategies and solutions available to clinical laboratories? Stop by for a Breakfast Discussion on Thursday, August 22nd, 7:30AM to hear Genosity’s President and CTO, Robert D. Daber, PhD, DABMG as he explores:
ArcherDX Announces Broad-Based Strategic Collaboration with Genosity
Feb 12 2019
BOULDER, Colo., Feb. 12, 2019 /PRNewswire/ — ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine, today announced that it has entered into a broad strategic collaboration with Genosity Inc., a biotechnology company that provides expertise, software and technical solutions to unlock the power of precision medicine by advancing genomics and facilitating collaborative research.
AMP 2018 Annual Meeting
Nov 1-3 2018, San Antonio, TX
Genosity will be exhibiting at the AMP annual meeting. Stop by our booth 1408 to find out about our new exciting products.
Bio-IT World Conference and Expo
May 15-17, 2018
Genosity will be exhibiting at the Bio-IT meeting. Stop by our booth 308 to meet us and learn what we have to offer.